Back to search
FDAFDA · Food and drugs·Recall number D-0662-2026

Methohexital Sodium for Injection, USP 500 mg Multiple Dose Vial, Rx Only, Manufactured by: OneSource Specialty, Pharma Limited, Bengaluru - 561 203, India, Manufactured for: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-893-31

Published July 15, 2026 · Recall initiated: June 7, 2026

Summary

FDA records drug Class II recall D-0662-2026, published July 15, 2026 and initiated June 7, 2026. Recalling firm: ONESOURCE SPECIALTY PHARMA LIMITED; Status: Ongoing; Reported quantity: 4284 vials; Lot: Lot #: 7000612A, Exp. Date 1/2028. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if METHOHEXITAL SODIUM has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
METHOHEXITAL SODIUM
Manufacturer
ONESOURCE SPECIALTY PHARMA LIMITED
Distributor
Nationwide within the United States
UPC
0323155893311
Lot
Lot #: 7000612A, Exp. Date 1/2028
Risk classification
Class II
Area (FDA)
drug
Country
India

Related recalls

Questions about this recall

Was Methohexital Sodium for Injection, USP 500 mg Multiple Dose Vial, Rx Only, Manufactured by: OneSource Specialty, Pharma Limited, Bengaluru - 561 203, India, Manufactured for: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-893-31 recalled?

Yes. FDA published recall D-0662-2026 on July 15, 2026. Reported hazard: Failed Impurities/Degradation Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: METHOHEXITAL SODIUM. UPC: 0323155893311.